Generic drug stocks will drive growth in 2025 News ad
Generic and biosimilar drugs are often preferred over brand-name drugs due to their lower price. Generics are exact copies of branded equivalents, while biosimilars are “similar” and often require clinical trials. Health insurance companies, Congress and patients love generics. This is a growing industry in the medical sector as drug patents typically expire 20 years … Read more
